Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

Cullinan Therapeutics (CGEM) shared updated clinical data from its Phase 1 study of CLN-049, a novel, investigational FLT3xCD3 bispecific T cell ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

ANAHEIM, Calif.--(BUSINESS WIRE)--Truvian Health, a transformational and data-driven diagnostics company, today presented results from a recent multi-site clinical study at the 2023 American ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee’s approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...